While conducting safety trials of experimental ultrasound therapy on a 12-year-old dog with a terminal-stage chondrosarcoma — its weakened pelvic bone so swollen the animal couldn’t stand ...

To identify potential therapeutic targets, this study investigated the molecular and immune landscape of three chondrosarcoma subtypes using a large database of clinical-grade sequencing results.